Stay updated on Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page

  1. Check
    10 days ago
    Change Detected
    Summary
    UI refresh of the study details page with updated layout and navigation; core study information such as eligibility criteria and outcomes remains unchanged.
    Difference
    0.0%
    Check dated 2026-04-12T11:17:24.000Z thumbnail image
  2. Check
    18 days ago
    No Change Detected
  3. Check
    25 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision updated to v3.5.0; previous revision v3.4.3 has been removed.
    Difference
    0.0%
    Check dated 2026-03-21T20:23:05.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Footer text updated from Revision: v3.4.2 to Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-07T13:21:31.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.4.2 instead of Revision: v3.4.1.
    Difference
    0.0%
    Check dated 2026-02-13T17:39:44.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the site footer. No study data, eligibility criteria, outcomes, or navigation were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:44:12.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 in the site footer. The previous revision label v3.4.0 has been removed.
    Difference
    0.0%
    Check dated 2026-02-05T14:28:25.000Z thumbnail image

Stay in the know with updates to Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Perjeta & Herceptin in HER2+ Breast Cancer Clinical Trial page.